Peer Review Policy

Bayrakol Medical Publishing implements a rigorous double-blind peer-review process for all submitted manuscripts. The identities of authors and reviewers remain confidential, and each submission is evaluated by at least two independent reviewers with expertise in the relevant field.

Peer Review Model

• Double-blind review for all submissions.
• Minimum two independent expert reviewers per manuscript.
• Confidential and impartial handling of all submissions.
• Constructive, objective, and evidence-based reviewer feedback.

Reviewer Selection & Independence

• Reviewers are selected based on subject expertise and academic qualifications.
• Reviewers from the same institution as the authors are not assigned.
• All reviewers must declare potential conflicts of interest prior to evaluation.

Evaluation Criteria

• Scientific validity and methodological rigor.
• Statistical accuracy and research quality.
• Ethical compliance and integrity of the study.
• Originality and contribution to the scientific field.
• Clarity, coherence, and completeness of the manuscript.

Review Process & Decisions

Reviewers are provided with a standard review period; if delays occur, alternative reviewers may be invited. Revised manuscripts may be re-reviewed by the same reviewers to ensure consistency. The final decision (accept, revise, reject) is made solely by the Editor-in-Chief.

Record Retention & Ethical Standards

All reviewer reports and editorial decisions are securely archived for a minimum of three (3) years to ensure transparency and auditability. Bayrakol Medical Publishing adheres to the COPE Ethical Guidelines for Peer Reviewers and follows COPE, ICMJE, and WAME recommendations in all peer-review procedures. In cases of suspected misconduct (plagiarism, data manipulation, ethical violations), COPE flowcharts and procedures are strictly applied.